CA
NZ
UK
AU
IND
US
Dr. Ronald Primas embodies a modern approach to health focused on longevity, incorporating strategies built on preventive medicine principles. He works as a concierge doctor in New York City, often managing patient appointments late into the night. Primas integrates daily exercise into his busy …
Telix Pharmaceuticals Limited (NASDAQ: TLX) shares closed down 9% at $11.33 despite reporting 1H revenue of $477 million as adjusted EBITDA surged 146% to $52 million.
Seres Therapeutics, Inc. (NASDAQ: MCRB) pivoted to a Q2 net profit of $4.6 million from a prior $19.9 million deficit, primarily fueled by a $25 million gain tied to VOWST and reduced overhead.
Decoy Therapeutics reported a 148% expansion in Q2 net losses to $2.37 million, primarily attributed to intensified R&D investments following the IMP3ACT program merger and legacy expenditure.
Senti Biosciences, Inc. (NASDAQ: SNTI) shares closed down 11% at $0.39 afterSubsidiarySenti Holdings finalized a $4 million senior secured convertible note issuance to Celadon Partners SPV 24.
SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) shares closed up 15% at $15.46 after Maxim reiterated its Buy rating and $30 price target, notably above the $27.50 market consensus.
Telix Pharmaceuticals Limited (NASDAQ: TLX) reported 1H revenue of $477 million as adjusted EBITDA surged 146% to $52 million, driven by robust product sales and a $40 million collaboration milestone from Regeneron.
Arbutus Biopharma Corporation (NASDAQ: ABUS) shares closed up 9% at $5.21 after the company announced a modified Dutch auction tender offer to buy back as much as $230 million in common stock at a price range of $5.00 to $5.75 per share.
Senti Biosciences, Inc. (NASDAQ: SNTI) subsidiary Senti Holdings finalized a $4 million senior secured convertible note issuance to Celadon Partners SPV 24, securing immediate funding.
Arbutus Biopharma Corporation (NASDAQ: ABUS) announced a modified Dutch auction tender offer to buy back as much as $230 million in common stock at a price range of $5.00 to $5.75 per share.
Please wait processing your request...